Association Between Light Spectrum and Survival After Cataract Surgery
NCT ID: NCT04187157
Last Updated: 2019-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10192 participants
OBSERVATIONAL
2012-01-01
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Light Filters in Intraocular Lenses (IOLs) and Its Influence on Colour and Contrast Vision.
NCT00612729
Effect of Blue Light Filtration on Visual Performance
NCT01938989
Quality of Life Evaluation After Cataract Surgery Using 4 Types of Intraocular Lens Implant Combinations
NCT05376917
The Effect of a Blue Light Filtering IOL
NCT00571831
Effect of the Color of the Intra-eye Implant in the Cataract Surgery on the Sleep
NCT02304900
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blue-light filtering intraocular lens (IOL)
Bilateral implantation of blue-filtering intraocular lens. Blue-IOL, in addition to ultraviolet, also impede the transmission of the lower visible blue spectrum between 400 and 500nm.
Blue-light filtering intraocular lens
Bilateral implantation of blue light-blocking intraocular lens
Conventional intraocular lens (IOL)
Bilateral implantation of conventional ultraviolet light-blocking intraocular lens
Conventional intraocular lens
Bilateral implantation of conventional intraocular lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blue-light filtering intraocular lens
Bilateral implantation of blue light-blocking intraocular lens
Conventional intraocular lens
Bilateral implantation of conventional intraocular lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthew Rosengart
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew R Rosengart, MD MPH
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UPMC-Presbyterian Hospital
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO18060034
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.